Analytik Jena AG Announces Group Figures for Financial Year 2010/2011

Analytik Jena AG Announces Group Figures for Financial Year 2010/2011

ID: 97264

(Thomson Reuters ONE) -
Analytik Jena AG /
Analytik Jena AG Announces Group Figures for Financial Year 2010/2011
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.

- Sales record based on sound business development
- Operating result considerably higher than previous year
- Result influenced by extraordinary tax expenses relating to other periods
- Growth expected for financial year 2011/2012 with a quieter first quarter

Jena, December 15, 2011 - In the past financial year 2010/2011, the Analytik
Jena AG (Frankfurt DE0005213508, Prime Standard: AJA) was again able to increase
its revenue significantly. Overall, the Group generated sales of EUR 86.3 m
(previous year: EUR 80.2 m), a 7.6 % increase on the previous year. In the
process, Analytik Jena again surpassed the record achieved in the previous year.
Operating profit (EBIT) amounted to EUR 5.0 m (previous year: EUR 3.1 m), up
59.3 % year-on-year.

"After the previous financial year was basically characterized by one-time
effects, we succeeded in growing our operating result again." commented Klaus
Berka, CEO of Analytik Jena AG. "We could again increase in sales and exceed the
record level of sales we set last year. We achieved this due to the outstanding
development in our largest business area, Analytical Instrumentation that
managed to grow its revenue by 11.3 % last year based on its traditionally
strong export operations."

Revenue Development and Segments

From a strong competitive position in the optical spectroscopy sector, the
Analytical Instrumentation business unit was again able to win market share in
the reporting period and increase its revenue. Analytik Jena closed the
financial year in this segment with revenue of EUR 53.2 m (previous year: EUR
47.8 m), representing a gain of 11.3 %. Life Science business unit recorded




sales of EUR 28.3 m (previous year: EUR 27.5 m), 2.7 % higher than in the
previous year. The Optics segment was able to halt a three-year downward slide
caused by economic conditions, nearly matching the previous year's level.
Revenue in financial year 2010/2011 totaled EUR 4.8 m (previous year: EUR 4.9
m). That equates to a slight decrease of 1.1 %.

Financial Position and Results of Operations

The Group ended the full financial year of 2010/2011 with earnings before
interest, taxes, depreciation, and amortization (EBITDA) of EUR 8.8 m (previous
year: EUR 6.7 m) and operating profit of EUR 5.0 m (previous year: EUR 3.1 m).
In the process, Analytik Jena recorded increases in EBITDA of 31.0 % and EBIT of
59.3 %. Once again, the Company achieved a double-digit EBITDA margin of 10.2 %
(previous year: 8.4 %). The EBIT margin was 5.8 % compared with 3.9 % in the
previous year. Therefore, Analytik Jena performed much better on an operating
basis than in the previous year.

The Group's tax expense totaled EUR 2.6 m (previous year: EUR 1.1 m). Of this
amount, EUR 0.8 m accrues to current actual tax expense and deferred tax income.
This corresponds to a tax rate of 27.6 %. In addition, tax expense of EUR 1.8 m
includes non-period tax expense resulting from the agreement with the Gera tax
office in financial year 2010/2011. The consolidated net profit for the year
fell compared with the amount for the previous year by 90.7 % and totaled EUR
0.2 m (previous year: EUR 2.1 m). For the shareholders of Analytik Jena AG both
basic and diluted earnings per share amounted to EUR -0.03 (previous year: EUR
0.34).

The Group's total assets as of the balance sheet date on September 30, 2011
remained similar to the previous year's level and amounted to EUR 83.6 m.

Human Resources

As of September 30, 2011, the Group had a total of 802 employees, including 38
interns (previous year: 796 employees, including 49 interns), or 0.8 % more than
as of the previous balance sheet date.

Outlook

With respect to the financial year 2011/2012, Analytik Jena expects that it will
be able to achieve further increases in revenue and earnings in all three
business units. The Company expects that revenue will be distributed relatively
evenly over the quarters and that no major disruptions will be caused by large
projects.

"The Company plans further investments in the expansion of the Thuringian
manufacturing site in Langewiesen amounting to about EUR 0.7 and remains clearly
committed to the manufacturing site Germany. Further important milestones are
the market launch of some product innovations that are meant to contribute to
the stable growth of the segments. We especially expect good impetus for the
expansion of our business from the prestigious international trade fairs IWA in
Nuremberg at the beginning of March concerning Optics and the 'analytica' in
April in Munich concerning both segments Analytical Instrumentation and Life
Science." Berka added.

The full financial report can be accessed at http://berichte.analytik-
jena.de/AnnualReport1011.pdf.

Contact:
Dana Schmidt, IR & Media Relations
Tel: +49 36 41 77-92 81
Fax: +49 36 41 77-99 88
ir(at)analytik-jena.de
www.analytik-jena.com







This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Analytik Jena AG via Thomson Reuters ONE

[HUG#1571508]


Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Telenor wins Statoil contract serving 20,000 employees Novartis drug Gilenya® showed positive clinical outcomes for relapsing-remitting MS patients in third large Phase III clinical trial
Bereitgestellt von Benutzer: hugin
Datum: 15.12.2011 - 07:00 Uhr
Sprache: Deutsch
News-ID 97264
Anzahl Zeichen: 6222

contact information:
Town:

Jena



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 159 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Analytik Jena AG Announces Group Figures for Financial Year 2010/2011"
steht unter der journalistisch-redaktionellen Verantwortung von

Analytik Jena AG (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Analytik Jena AG



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z